vimarsana.com
Home
Live Updates
Allegedly Infringing Product Continues to be on Clinical Tri
Allegedly Infringing Product Continues to be on Clinical Tri
Allegedly Infringing Product Continues to be on Clinical Trial RaDaRs | Irwin IP LLP
Rs Natera, Inc. v. NeoGenomics Laboratories, Inc., 23-cv-00629 (M.D.N.C. 2023) - How should courts resolve patent infringement disputes where patients rely on allegedly...
Related Keywords
North Carolina ,
United States ,
,
Neogenomics Laboratories Inc ,
Rs Natera Inc ,
Us District Court ,
District Of North Carolina The Court ,
Genomics Laboratories ,
Middle District ,